Apellis Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
CEOCedric Francois
CEOCedric Francois
Employees710
Employees710
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2009
Founded2009
Employees710
Employees710
APLS Key Statistics
Market cap2.95B
Market cap2.95B
Price-Earnings ratio-12.68
Price-Earnings ratio-12.68
Dividend yield—
Dividend yield—
Average volume2.34M
Average volume2.34M
High today$23.79
High today$23.79
Low today$23.17
Low today$23.17
Open price$23.67
Open price$23.67
Volume1.71M
Volume1.71M
52 Week high$37.84
52 Week high$37.84
52 Week low$16.10
52 Week low$16.10
APLS News
TipRanks 6d
Top Executive Sells Thousands of Apellis Pharmaceuticals Shares!New insider activity at Apellis Pharmaceuticals ( (APLS) ) has taken place on September 12, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Pr...
Analyst ratings
62%
of 21 ratingsBuy
61.9%
Hold
38.1%
Sell
0%
People also own
Based on the portfolios of people who own APLS. This list is generated using Robinhood data, and it’s not a recommendation.